跨表型荟萃分析识别川崎病与IgA血管炎共享遗传风险位点
该研究整合欧洲人群川崎病与IgA血管炎的基因组数据进行跨疾病荟萃分析,发现rs3743841达到全基因组显著性(P=8.06×10-10),该位点位于NAGPA基因内含子,对两种儿童血管炎具有多效性,是迄今IgA血管炎最强的非HLA信号。
要点
- rs3743841与川崎病和IgA血管炎共享风险相关,P=8.06×10-10。
- 单独分析IgA血管炎时rs3743841关联显著,OR=1.47(95%CI 1.27,1.69)。
- 该位点可能调控NAGPA和SEC14L5基因表达。
核心结论
- 识别出对川崎病和IgA血管炎具有多效性的新风险位点rs3743841,为IgA血管炎最强的非HLA信号。
研究设计与样本
- 发现阶段联合405例川崎病与6252例对照及215例IgA血管炎与1324例对照的欧洲人群基因组数据,采用逆方差荟萃分析。
- top相关多态性在额外独立队列(570例病例和3726例对照)中复制。
主要发现
- rs3743841在跨疾病荟萃分析中达到全基因组显著性(P=8.06×10-10)。
- 单独分析IgA血管炎时,rs3743841关联显著(P=1.25×10-7;OR=1.47,95%CI 1.27,1.69)。
- 计算机功能注释提示该多态性作为调控变异影响NAGPA和SEC14L5基因表达水平。
关键数值与推荐
- 全局IgA血管炎-川崎病荟萃分析中P值≤5×10-8的多态性被视为共享遗传风险位点。
临床怎么用
- 该共享位点有助于理解两种儿童血管炎的共同遗传机制,并可能为未来风险分层提供线索。
局限性
- 研究仅纳入欧洲人群,结果外推至其他人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Combining of genomic data of different pathologies as a single phenotype has emerged as a useful strategy to identify genetic risk loci shared among immune-mediated diseases. Our study aimed to increase our knowledge of the genetic contribution to Kawasaki disease (KD) and IgA vasculitis (IgAV) by performing the first comprehensive large-scale analysis on the genetic overlap between them. METHODS: A total of 1190 vasculitis patients and 11 302 healthy controls were analysed. First, in the discovery phase, genome-wide data of 405 KD patients and 6252 controls and 215 IgAV patients and 1324 controls, all of European origin, were combined using an inverse variance meta-analysis. Second, the top associated polymorphisms were selected for replication in additional independent cohorts (570 cases and 3726 controls). Polymorphisms with P-values ≤5 × 10-8 in the global IgAV-KD meta-analysis were considered as shared genetic risk loci. RESULTS: A genetic variant, rs3743841, located in an intron of the NAGPA gene, reached genome-wide significance in the cross-disease meta-analysis (P = 8.06 × 10-10). Additionally, when IgAV was individually analysed, a strong association between rs3743841 and this vasculitis was also evident [P = 1.25 × 10-7; odds ratio = 1.47 (95% CI 1.27, 1.69)]. In silico functional annotation showed that this polymorphism acts as a regulatory variant modulating the expression levels of the NAGPA and SEC14L5 genes. CONCLUSION: We identified a new risk locus with pleiotropic effects on the two childhood vasculitides analysed. This locus represents the strongest non-HLA signal described for IgAV to date.
引用
- Carmona EG, García-Giménez JA, López-Mejías R, et al. Identification of a shared genetic risk locus for Kawasaki disease and immunoglobulin A vasculitis by a cross-phenotype meta-analysis. Rheumatology (Oxford). 2022. PMID: 33993232. doi:10.1093/rheumatology/keab443
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。